Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2001. Start Trial.
Date Value
November 13, 2026 4.059
November 12, 2026 4.074
November 11, 2026 4.071
November 10, 2026 4.122
November 09, 2026 4.147
November 06, 2026 4.049
November 05, 2026 4.056
November 04, 2026 4.115
November 03, 2026 3.918
November 02, 2026 3.953
October 30, 2026 3.984
October 29, 2026 3.917
October 28, 2026 3.922
October 27, 2026 4.098
October 26, 2026 4.111
October 23, 2026 4.083
October 22, 2026 4.120
October 21, 2026 4.024
October 20, 2026 4.074
October 19, 2026 3.979
October 16, 2026 3.984
October 15, 2026 3.944
October 14, 2026 3.852
October 13, 2026 3.723
October 12, 2026 3.775
Date Value
October 09, 2026 3.741
October 08, 2026 3.744
October 07, 2026 3.783
October 06, 2026 3.749
October 05, 2026 3.745
October 02, 2026 3.784
October 01, 2026 3.796
September 30, 2026 3.876
September 29, 2026 4.262
September 28, 2026 4.292
September 25, 2026 4.253
September 24, 2026 4.288
September 23, 2026 4.293
September 22, 2026 4.381
September 21, 2026 4.412
September 18, 2026 4.337
September 17, 2026 4.41
September 16, 2026 4.344
September 15, 2026 4.319
September 14, 2026 4.323
September 11, 2026 4.157
September 10, 2026 4.156
September 09, 2026 4.200
September 08, 2026 4.192
September 04, 2026 4.309

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
AstraZeneca PLC 12.09
Johnson & Johnson 8.437
Eli Lilly & Co. 33.74
Merck & Co., Inc. 8.119
Novo Nordisk A/S 5.561

Price to Book Value Related Metrics